文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

1.5T磁共振引导自适应立体定向体部放疗期间前列腺体积变化及其与治疗毒性的相关性

Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity.
PubMed 文献 · Radiother Oncol · 2023-12-04

在前瞻性研究中,低至中危前列腺癌患者接受5次分割的1.5T MR-linac每日自适应SBRT,总剂量35 Gy或36.25 Gy每日或隔日照射。254例分析显示前列腺体积从首次到末次分次平均增加6.4%(P<0.0001),50%病例肿胀、39%稳定、11%缩小,体积变化与患者报告结局(IPSS、ICIQ-SF、EPIC-26)无相关性。

要点

  • 前列腺SBRT期间平均体积从58.9 cc增至62.7 cc(平均增加6.4%,P<0.0001)。
  • 50%病例前列腺肿胀(平均增加15.4%),11%缩小(平均减少12.2%)。
  • CTV体积变化与IPSS、ICIQ-SF、EPIC-26等PROMs均无相关性。

核心结论

  • 1.5T MR-linac上前列腺SBRT期间前列腺体积发生显著变化,半数病例肿胀、少数缩小,在该每日自适应策略治疗人群中未发现体积变化与PROMs的相关性。

研究设计与样本

  • 前瞻性研究(方案编号23748)纳入低至中危前列腺癌患者,接受5次分割SBRT,总剂量35 Gy和36.25 Gy每日或隔日照射,共254例纳入分析。

主要发现

  • 基线CTV体积中位数55 cc(范围15.3-163.3),首次和末次分次平均前列腺体积分别为58.9 cc和62.7 cc(平均增加6.4%,P<0.0001)。
  • 50%病例出现前列腺肿胀(平均增加15.4%),39%病例体积稳定(变化≤5%),11%病例前列腺缩小(平均减少12.2%)。
  • 基线CTV>55 cc显示CTV缩小更多的趋势(-10.5% vs -14.5%,P=0.052)。
  • 未发现CTV变化与PROMs的相关性;前列腺肿胀通常被计划PTV外扩所补偿,但末次分次平均摆位体积从47.4 cc降至38.9 cc,少数病例未被初始摆位边界覆盖。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To evaluate prostate volume change during daily-adaptive prostate SBRT on 1.5 T MR-linac and to correlate it with treatment toxicity. METHODS: a series of patients affected by low-to-intermediate risk prostate cancer was treated by 5-fraction SBRT within a prospective study (Prot. n° 23748). Total dose was 35 Gy and 36.25 Gy delivered every day or on alternate days. Treatment toxicity was recorded with the following patient reported outcomes (PROMs): IPSS, ICIQ-SF, and EPIC-26. RESULTS: 254 patients were included in the analysis. Baseline median CTV volume was 55 cc (range 15.3-163.3). Mean prostate volume were 58.9 cc, and 62.7 cc at first and last fraction respectively (mean volume increase 6.4 %; p = <0.0001). We observed prostate swelling (mean 15.4 % increase) in 50 % of cases, stable volume (≤5% volume change) in 39 % of patients, and prostate shrinkage in 11 % of cases (mean 12.2 % reduction). Baseline CTV > 55 cc showed a trend towards higher CTV shrinkage (-10.5 % versus -14.5 %; p = 0.052). We found no correlation between CTV change and PROMs. Prostate swelling was generally compensated by the planned PTV expansion, even though the mean setup volume dropped from 47.4 cc to 38.9 cc at last fraction, with few cases not covered by initial setup margins. CONCLUSION: The present study reported a significant prostate volume change during prostate SBRT on 1.5T MR-linac. We observed both prostate swelling in half of cases and few cases of prostate shrinkage. No correlations were found with PROMs in this population treatment with daily-adaptive strategy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Nicosia L, Ravelli P, Rigo M, et al. Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity. Radiother Oncol. 2023. PMID: 38056694. doi:10.1016/j.radonc.2023.110043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。